- Home
- AXGN vs PDT Comparison
AXGN vs PDT Comparison
Compare AXGN & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- PDT
- Stock Information
- Founded
- AXGN N/A
- PDT 1989
- Country
- AXGN United States
- PDT United States
- Employees
- AXGN 428
- PDT N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PDT Finance Companies
- Sector
- AXGN Health Care
- PDT Finance
- Exchange
- AXGN Nasdaq
- PDT Nasdaq
- Market Cap
- AXGN 648.7M
- PDT 648.3M
- IPO Year
- AXGN N/A
- PDT N/A
- Fundamental
- Price
- AXGN $14.77
- PDT $12.33
- Analyst Decision
- AXGN Strong Buy
- PDT
- Analyst Count
- AXGN 4
- PDT 0
- Target Price
- AXGN $15.00
- PDT N/A
- AVG Volume (30 Days)
- AXGN 201.0K
- PDT 145.6K
- Earning Date
- AXGN 11-07-2024
- PDT 01-01-0001
- Dividend Yield
- AXGN N/A
- PDT 8.88%
- EPS Growth
- AXGN N/A
- PDT N/A
- EPS
- AXGN N/A
- PDT N/A
- Revenue
- AXGN $180,855,000.00
- PDT N/A
- Revenue This Year
- AXGN $18.91
- PDT N/A
- Revenue Next Year
- AXGN $13.02
- PDT N/A
- P/E Ratio
- AXGN N/A
- PDT N/A
- Revenue Growth
- AXGN 18.79
- PDT N/A
- 52 Week Low
- AXGN $5.55
- PDT $8.77
- 52 Week High
- AXGN $15.90
- PDT $13.05
- Technical
- Relative Strength Index (RSI)
- AXGN 57.98
- PDT 26.94
- Support Level
- AXGN $13.85
- PDT $12.51
- Resistance Level
- AXGN $14.80
- PDT $13.08
- Average True Range (ATR)
- AXGN 0.51
- PDT 0.19
- MACD
- AXGN 0.02
- PDT -0.07
- Stochastic Oscillator
- AXGN 67.79
- PDT 0.00
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund II is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, and short-term investments.